デフォルト表紙
市場調査レポート
商品コード
1585679

バイオテクノロジー試薬・キット市場:タイプ別、微生物別、技術別、検査項目別、目的別、最終用途別-2025~2030年世界予測

Biotechnology Reagents & Kits Market by Type (Amplification Kits, Detection Kits, Isolation Kits), Micro-Organisms (Bacteria, Fungi, Parasites), Technology, Tested Parameters, Purpose, End-Use - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 185 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
バイオテクノロジー試薬・キット市場:タイプ別、微生物別、技術別、検査項目別、目的別、最終用途別-2025~2030年世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオテクノロジー試薬・キット市場の2023年の市場規模は5,447億6,000万米ドルで、2024年には6,404億1,000万米ドルに達すると予測され、CAGR 17.65%で成長し、2030年には1兆6,997億4,000万米ドルに達すると予測されています。

バイオテクノロジー試薬・キット市場には、DNA/RNA分析、タンパク質アッセイ、細胞培養などのプロセスに不可欠なコンポーネントを含む、バイオテクノロジー研究と用途で使用される幅広い製品が含まれます。これらの試薬は、科学研究、医薬品開発、診断、個別化医療の進展に不可欠です。医療、農業、環境科学など様々なセグメントで応用されています。バイオ医薬品に対する需要の高まり、研究開発への投資の増加、新興国における医療インフラの拡充が市場の成長を後押ししています。CRISPRや次世代シーケンサーのような新技術の採用は、その必要性をさらに高めています。しかし、厳しい規制当局の承認、試薬の高コスト、バイオテクノロジー研究における倫理的問題などの課題が、市場成長の妨げとなる可能性があります。費用対効果が高く、サステイナブル試薬やキットの開発、合成生物学の進歩、バイオテクノロジー研究におけるAIの統合の進展など、技術革新の可能性が広がっています。市場競争は激しく、各社は競合を維持するために戦略的提携や製品イノベーションに注力しています。新興市場は、医療ニーズと研究活動の増加により、大きな成長機会を提供しています。こうした機会を生かすため、企業は環境に優しい試薬の開発、製品ポートフォリオの精度と効率の向上、製品流通を合理化するための戦略的提携に注力すべきです。特に、研究所のワークフローを簡素化し、多機能用途を提供するキットの開発に重点を置いたイノベーションが期待できます。市場は急速な技術進歩を特徴としており、継続的な技術革新と、検査工程の自動化や小型化といった動向への適応が求められます。全体として、サステイナブル成長のためには、企業は研究開発、顧客エンゲージメントに投資し、様々な国際規制へのコンプライアンスを維持しながら、十分に浸透していない地域市場でのプレゼンスを拡大する必要があります。

主要市場の統計
基準年[2023年] 5,447億6,000万米ドル
予測年[2024年] 6,404億1,000万米ドル
予測年[2030年] 1兆6,997億4,000万米ドル
CAGR(%) 17.65%

市場力学:急速に進化するバイオテクノロジー試薬・キット市場の主要市場洞察を公開

バイオテクノロジー試薬・キット市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • タンパク質プロファイリング用途における研究活動の増加
    • 進化するバイオテクノロジー技術の展望
    • がん、遺伝性疾患、慢性感染症の負担増
  • 市場抑制要因
    • バイオ試薬の高コストとキットに関連する汚染の問題
  • 市場機会
    • バイオテクノロジー企業による高い研究開発費
    • バイオテクノロジー新興企業や研究所の増加
  • 市場課題
    • 試薬の承認に関する政府の厳しい規制

ポーターのファイブフォース:バイオテクノロジー試薬・キット市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:バイオテクノロジー試薬・キット市場における外部からの影響の把握

外部マクロ環境要因は、バイオテクノロジー試薬・キット市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析:バイオテクノロジー試薬・キット市場における競合情勢の把握

バイオテクノロジー試薬・キット市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックスバイオテクノロジー試薬・キット市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バイオテクノロジー試薬・キット市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨:バイオテクノロジー試薬・キット市場における成功への道筋を描く

バイオテクノロジー試薬・キット市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、地域はどこか?

3.市場を形成する主要技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • タンパク質プロファイリング用途における調査活動の増加
      • バイオ情勢技術の進化
      • がん、遺伝性疾患、慢性感染症の負担が増大
    • 抑制要因
      • バイオテクノロジー試薬の高コストとキットに関連する汚染問題
    • 機会
      • バイオテクノロジー企業による高額な研究開発費
      • バイオテクノロジーの新興企業と研究所の増加
    • 課題
      • 試薬の承認に関する厳格な政府規制
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 法律
    • 環境

第6章 バイオテクノロジー試薬・キット市場:タイプ別

  • イントロダクション
  • 増幅キット
  • 検出キット
  • 分離キット
  • 浄化キット

第7章 バイオテクノロジー試薬・キット市場:微生物別

  • イントロダクション
  • 細菌
  • 菌類
  • 寄生虫
  • ウイルス

第8章 バイオテクノロジー試薬・キット市場:技術別

  • イントロダクション
  • 細胞培養
  • クロマトグラフィー
  • 電気泳動
  • フローサイトメトリー
  • LAMP技術
  • PCR
  • シーケンシング

第9章 バイオテクノロジー試薬・キット市場:検査項目別

  • イントロダクション
  • DNA
  • 酵素
  • タンパク質
  • RNA

第10章 バイオテクノロジー試薬・キット市場:目的別

  • イントロダクション
  • 研究所
  • 現場

第11章 バイオテクノロジー試薬・キット市場:最終用途別

  • イントロダクション
  • 食品と農業
  • 医療
  • 工業処理
  • 天然資源と環境

第12章 南北アメリカのバイオテクノロジー試薬・キット市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第13章 アジア太平洋のバイオテクノロジー試薬・キット市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第14章 欧州・中東・アフリカのバイオテクノロジー試薬・キット市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第15章 競合情勢

  • 市場シェア分析、2023年
  • FPNVポジショニングマトリックス、2023年
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomerieux, Inc.
  • Danaher Corporation
  • ELK BIoTechnology Co. Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Illumina, Inc.
  • LGC Limited
  • Lonza Group Ltd.
  • Merck KGaA
  • New England Biolabs
  • Omega Bio-tek, Inc.
  • Promega Corporation
  • QIAGEN GmbH
  • Sartorius AG
  • Siemens Healthineers AG
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • Toyobo Co., Ltd.
  • Volpara Health Technologies
  • Water Corporation
図表

LIST OF FIGURES

  • FIGURE 1. BIOTECHNOLOGY REAGENTS & KITS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. BIOTECHNOLOGY REAGENTS & KITS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. BIOTECHNOLOGY REAGENTS & KITS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOTECHNOLOGY REAGENTS & KITS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOTECHNOLOGY REAGENTS & KITS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY AMPLIFICATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY DETECTION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY ISOLATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURIFICATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY BACTERIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY FUNGI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PARASITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY VIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY LAMP TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY DNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY RNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY ON-SITE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY FOOD & AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY INDUSTRIAL PROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY NATURAL RESOURCES & ENVIRONMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 130. SINGAPORE BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH KOREA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 142. TAIWAN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 148. THAILAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 154. VIETNAM BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 167. DENMARK BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 173. EGYPT BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 179. FINLAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 185. FRANCE BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 191. GERMANY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 197. ISRAEL BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 203. ITALY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 215. NIGERIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 221. NORWAY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 227. POLAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 233. QATAR BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 239. RUSSIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 257. SPAIN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 263. SWEDEN BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 275. TURKEY BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY MICRO-ORGANISMS, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY TESTED PARAMETERS, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED KINGDOM BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY PURPOSE, 2018-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM BIOTECHNOLOGY REAGENTS & KITS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 288. BIOTECHNOLOGY REAGENTS & KITS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 289. BIOTECHNOLOGY REAGENTS & KITS MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-3E7F10ED1B58

The Biotechnology Reagents & Kits Market was valued at USD 544.76 billion in 2023, expected to reach USD 640.41 billion in 2024, and is projected to grow at a CAGR of 17.65%, to USD 1,699.74 billion by 2030.

The biotechnology reagents and kits market encompasses a broad range of products used in biotechnological research and applications, including components vital for processes like DNA/RNA analysis, protein assays, and cell culture. These reagents are crucial for advancing scientific research, drug development, diagnostics, and personalized medicine. They find applications in various sectors, including healthcare, agriculture, and environmental science. The growing demand for biopharmaceuticals, increasing investment in R&D, and the expansion of healthcare infrastructure in emerging economies drive the market's growth. Adoption of novel technologies like CRISPR and next-generation sequencing further amplifies their necessity. However, challenges such as stringent regulatory approvals, high cost of reagents, and ethical issues in biotechnology research can hinder market growth. Opportunities abound in the development of cost-effective, sustainable reagents and kits, along with advancements in synthetic biology and the greater integration of AI in biotechnological research, offering avenues for innovation. The market is highly competitive, with players focusing on strategic collaborations and product innovations to maintain a competitive edge. Emerging markets provide significant growth opportunities due to increasing healthcare needs and research activities. To capitalize on these opportunities, companies should focus on developing eco-friendly reagents, enhancing their product portfolio's accuracy and efficiency, and engaging in strategic partnerships to streamline product distribution. Innovations can particularly focus on developing kits that simplify laboratory workflows and offer multifunctional applications. The market is characterized by rapid technological progression, demanding continuous innovation and adaptation to trends such as automation and miniaturization of laboratory processes. Overall, for sustainable growth, businesses should invest in R&D, customer engagement, and expand their presence in underpenetrated regional markets, while maintaining compliance with varying international regulations.

KEY MARKET STATISTICS
Base Year [2023] USD 544.76 billion
Estimated Year [2024] USD 640.41 billion
Forecast Year [2030] USD 1,699.74 billion
CAGR (%) 17.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biotechnology Reagents & Kits Market

The Biotechnology Reagents & Kits Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased research activities in protein profiling applications
    • Evolving landscape for the biotechnology techniques
    • Growing burden of cancer, genetic disorders and chronic infectious disease
  • Market Restraints
    • High costs of biotechnology reagents and contamination issues associated with kits
  • Market Opportunities
    • High R&D expenditure by biotechnology companies
    • Rise in number of biotechnology startups and laboratories
  • Market Challenges
    • Stringent government regulations for approval of reagents

Porter's Five Forces: A Strategic Tool for Navigating the Biotechnology Reagents & Kits Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biotechnology Reagents & Kits Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biotechnology Reagents & Kits Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biotechnology Reagents & Kits Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biotechnology Reagents & Kits Market

A detailed market share analysis in the Biotechnology Reagents & Kits Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biotechnology Reagents & Kits Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biotechnology Reagents & Kits Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biotechnology Reagents & Kits Market

A strategic analysis of the Biotechnology Reagents & Kits Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biotechnology Reagents & Kits Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerieux, Inc., Danaher Corporation, ELK Biotechnology Co. Ltd., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., GE Healthcare, Illumina, Inc., LGC Limited, Lonza Group Ltd., Merck KGaA, New England Biolabs, Omega Bio-tek, Inc., Promega Corporation, QIAGEN GmbH, Sartorius AG, Siemens Healthineers AG, Takara Bio, Inc., Thermo Fisher Scientific, Inc., Toyobo Co., Ltd., Volpara Health Technologies, and Water Corporation.

Market Segmentation & Coverage

This research report categorizes the Biotechnology Reagents & Kits Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Amplification Kits, Detection Kits, Isolation Kits, and Purification Kits.
  • Based on Micro-Organisms, market is studied across Bacteria, Fungi, Parasites, and Virus.
  • Based on Technology, market is studied across Cell Culture, Chromatography, Electrophoresis, Flow Cytometry, LAMP Technology, PCR, and Sequencing.
  • Based on Tested Parameters, market is studied across DNA, Enzymes, Proteins, and RNA.
  • Based on Purpose, market is studied across Laboratory and On-Site.
  • Based on End-Use, market is studied across Food & Agriculture, Healthcare, Industrial Processing, and Natural Resources & Environment.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased research activities in protein profiling applications
      • 5.1.1.2. Evolving landscape for the biotechnology techniques
      • 5.1.1.3. Growing burden of cancer, genetic disorders and chronic infectious disease
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of biotechnology reagents and contamination issues associated with kits
    • 5.1.3. Opportunities
      • 5.1.3.1. High R&D expenditure by biotechnology companies
      • 5.1.3.2. Rise in number of biotechnology startups and laboratories
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations for approval of reagents
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biotechnology Reagents & Kits Market, by Type

  • 6.1. Introduction
  • 6.2. Amplification Kits
  • 6.3. Detection Kits
  • 6.4. Isolation Kits
  • 6.5. Purification Kits

7. Biotechnology Reagents & Kits Market, by Micro-Organisms

  • 7.1. Introduction
  • 7.2. Bacteria
  • 7.3. Fungi
  • 7.4. Parasites
  • 7.5. Virus

8. Biotechnology Reagents & Kits Market, by Technology

  • 8.1. Introduction
  • 8.2. Cell Culture
  • 8.3. Chromatography
  • 8.4. Electrophoresis
  • 8.5. Flow Cytometry
  • 8.6. LAMP Technology
  • 8.7. PCR
  • 8.8. Sequencing

9. Biotechnology Reagents & Kits Market, by Tested Parameters

  • 9.1. Introduction
  • 9.2. DNA
  • 9.3. Enzymes
  • 9.4. Proteins
  • 9.5. RNA

10. Biotechnology Reagents & Kits Market, by Purpose

  • 10.1. Introduction
  • 10.2. Laboratory
  • 10.3. On-Site

11. Biotechnology Reagents & Kits Market, by End-Use

  • 11.1. Introduction
  • 11.2. Food & Agriculture
  • 11.3. Healthcare
  • 11.4. Industrial Processing
  • 11.5. Natural Resources & Environment

12. Americas Biotechnology Reagents & Kits Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Biotechnology Reagents & Kits Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Biotechnology Reagents & Kits Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies, Inc.
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Biomerieux, Inc.
  • 6. Danaher Corporation
  • 7. ELK Biotechnology Co. Ltd.
  • 8. Eurofins Scientific SE
  • 9. F. Hoffmann-La Roche Ltd.
  • 10. GE Healthcare
  • 11. Illumina, Inc.
  • 12. LGC Limited
  • 13. Lonza Group Ltd.
  • 14. Merck KGaA
  • 15. New England Biolabs
  • 16. Omega Bio-tek, Inc.
  • 17. Promega Corporation
  • 18. QIAGEN GmbH
  • 19. Sartorius AG
  • 20. Siemens Healthineers AG
  • 21. Takara Bio, Inc.
  • 22. Thermo Fisher Scientific, Inc.
  • 23. Toyobo Co., Ltd.
  • 24. Volpara Health Technologies
  • 25. Water Corporation